Viewing Study NCT01962532


Ignite Creation Date: 2025-12-24 @ 9:36 PM
Ignite Modification Date: 2025-12-31 @ 1:45 AM
Study NCT ID: NCT01962532
Status: COMPLETED
Last Update Posted: 2019-05-15
First Post: 2013-07-26
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of JNJ-42756493 in Patients With Advanced or Refractory Solid Tumors or Lymphoma
Sponsor: Janssen Research & Development, LLC
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2013-08-21
Start Date Type: ACTUAL
Primary Completion Date: 2016-01-28
Primary Completion Date Type: ACTUAL
Completion Date: 2016-01-28
Completion Date Type: ACTUAL
First Submit Date: 2013-07-26
First Submit QC Date: None
Study First Post Date: 2013-10-14
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2019-05-13
Last Update Post Date: 2019-05-15
Last Update Post Date Type: ACTUAL